查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1717923

动物血浆产品及衍生物市场（依动物类型、衍生物类型、最终用户及应用）－2025 年至 2030 年全球预测

Animal Blood Plasma Products & Derivatives Market by Animal Type, Derivative Type, End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年兽用血浆产品及衍生物市场价值为 15.2 亿美元，预计 2025 年将达到 16.3 亿美元，预计到 2030 年将以 7.71% 的复合年增长率增长，达到 23.7 亿美元。

主要市场统计数据
基准年2024年 15.2亿美元
预计2025年 16.3亿美元
预测年份 2030 23.7亿美元
复合年增长率（%） 7.71%

动物血浆产品及其衍生物已逐渐成为研究和工业应用的重要焦点。多年来，由于各领域对高品质生物材料的需求不断扩大，市场经历了显着增长。这份深入的报告提供了对该行业的广泛看法，阐明了从传统方法到应对现代挑战的创新、科学主导的解决方案的演变。

该行业目前正处于科学进步和市场需求的十字路口。在生物技术投资和先进研究力度不断增加的推动下，萃取和精製製程的突破优化了动物血浆衍生物的功效。这些改进也转化为品质和可靠性的提高，使我们的产品在广泛的应用中不可或缺。随着需求的增长，新的安全、监管和技术基准也在不断发展。

这项全面的分析深入探讨了关键的市场驱动因素，为讨论变革性转变和细分见解奠定了基础。它还检验了区域成长的细微差别、主要企业的策略以及决策者的可行见解。强调研究在改进现有产品和探索新衍生物方面的作用，突显充满活力和先进的市场。随着平衡品质、成本和监管要求的需求不断增加，本概述为深入探索市场光明的未来奠定了基础。

影响产业格局的变革时期

近年来，兽用血浆产品及衍生市场经历了几次变化。製程创新与先进分析工具的结合重塑了生产效率和产品品质。改进的精製方法产生了更一致的衍生产品，有助于满足严格的监管标准和不断提高的消费者期望。

市场也受到显着技术进步的影响，例如生产线自动化、品管的人工智慧整合以及流程优化的数据驱动方法。这些变化不仅降低了製造成本，而且使生产扩充性，使製造商能够满足不断增长的全球需求。同时，不断变化的监管环境迫使企业提高透明度和合规性，直接影响其市场营运和长期策略。

同时，业内企业也加大研发投入，探索传统动物血浆衍生物以外的新应用。多学科合作和伙伴关係的趋势明显，这将进一步加速产品创新。随着新兴市场和成熟市场需求的增加，製造商正在重新定义产品系列，以满足从生物医学研究到消费性产品的更广泛的应用。这种策略转变凸显了市场的流动性，技术创新和不断变化的法规为产业的持续成长铺平了道路。

对不断发展的市场的关键细分洞察

详细的細項分析揭示了兽用血浆产品及其衍生物的市场动态。该行业根据动物类型、衍生类型、最终用户和应用进行细分。从动物种类来看，重点是家禽、牛、羊、猪等动物製品。每个类别都具有独特的特性，可满足各种应用中的特定产品需求。

此外，衍生型细分包括牛、纤维蛋白原、免疫球蛋白、血清白蛋白、凝血酶等必需产品。这些成分是广泛生物医学应用的基础，有助于研究和治疗。最终用户包括食品製造商、製药公司和兽医诊所。这种多样性证明了等离子产品的多功能性和广泛的适用性，可以解决特定产业的挑战。

基于应用的市场区隔进一步凸显了市场的进化性质，产品服务于动物饲料、生物医学研究、细胞培养基、食品加工等领域。其他应用包括营养补充品、宠物食品产业配方、药品、化妆品和组织工程。这种市场区隔洞察表明，市场高度专业化，每个细分市场都反映了不同的消费者需求和技术创新，从而推动了产品开发和策略市场定位。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 人类对动物肉和蛋白质的需求不断增加
      • 全球消费者对永续和人道动物养殖实践的认识正在不断提高
      • 扩大动物血浆在兽医学的应用
    • 限制因素
      • 对动物血浆产品安全和品质标准的严格规定
    • 机会
      • 血浆衍生物在化妆品和护肤中的新兴用途，用于创新产品开发
      • 不断创新生物技术和加工技术，提升动物血浆产品的品质
    • 任务
      • 动物血浆产品合成替代品的可用性
  • 市场区隔分析
    • 动物类型：猪血浆产品因其高效率和氨基酸含量而越来越受欢迎。
    • 应用：动物血浆产品在宠物食品产业的重要性日益增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 动物血浆产品及衍生性商品市场（依动物类型）

  • 鸟类
  • 牛
  • 羊
  • 猪

第七章动物血浆产品及衍生性商品市场（依衍生类型）

  • 牛
  • 纤维蛋白原
  • 免疫球蛋白
  • 血清白蛋白
  • 凝血酶

8. 动物血浆产品及衍生性商品市场（依最终用户）

  • 食品製造商
  • 製药公司
  • 兽医

第九章动物血浆产品及衍生性商品市场：依应用

  • 动物饲料
  • 生物医学研究
  • 细胞培养基
  • 食品加工
  • 营养补充品
  • 宠物食品业
  • 药品和化妆品
  • 组织工程

10.美洲动物血浆产品及衍生物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11. 亚太地区动物血浆产品及衍生性商品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东及非洲动物血浆产品及衍生性商品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • ACROBiosystems Inc.
  • Alfa Laval Corporate AB
  • ANZCO Foods Limited
  • Auckland BioSciences Ltd.
  • BioChemed Services
  • Biowest Company
  • Bovogen Biologicals Pty Ltd.
  • Canvax Reagents SL
  • Ebrator Biochemicals Inc.
  • Kraeber & Co. GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories, Inc.
  • Meiji Holdings Co., Ltd.
  • Merck KGaA
  • Pel-Freez, LLC
  • Rockland Immunochemicals, Inc.
  • Rocky Mountain Biologicals
  • Scripps Laboratories, Inc.
  • Sigma-Aldrich
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-69324464D0E2

The Animal Blood Plasma Products & Derivatives Market was valued at USD 1.52 billion in 2024 and is projected to grow to USD 1.63 billion in 2025, with a CAGR of 7.71%, reaching USD 2.37 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.52 billion
Estimated Year [2025] USD 1.63 billion
Forecast Year [2030] USD 2.37 billion
CAGR (%) 7.71%

Animal blood plasma products and derivatives have steadily emerged as a critical focus in both research and industrial applications. Over the years, the market has experienced significant growth driven by the expanding need for high-quality biological materials in various sectors. This in-depth report provides an expansive view of the industry, elucidating the evolution from traditional methodologies to innovative, science-driven solutions that meet modern-day challenges.

The industry now stands at the crossroads of scientific advancement and market demand. Fueled by increased investment in biotechnology and progressive research efforts, significant breakthroughs in extraction and purification processes have optimized the efficacy of animal plasma derivatives. These improvements have also translated into enhanced quality and reliability, making the products indispensable across multiple applications. As the demand grows, new safety, regulatory, and technological benchmarks continue to evolve.

This comprehensive analysis delves into key market drivers, laying the groundwork for a discussion on transformative shifts and segmented insights. The report also examines the nuances of regional growth, the strategies of industry-leading companies, and actionable insights for decision-makers. The role of research in refining existing products while also exploring novel derivatives is underscored, highlighting a market that is both dynamic and forward-thinking. With an ever-increasing need to balance quality, cost, and regulatory requirements, the overview sets the stage for a detailed exploration of the market's promising future.

Transformative Shifts Impacting the Industry Landscape

Recent years have witnessed several transformative shifts in the animal blood plasma products and derivatives market. Innovations in processing techniques combined with advanced analytical tools have reshaped production efficiency and product quality. Enhanced purification methods now allow for greater consistency in derived products, meeting both stringent regulatory criteria and evolving consumer expectations.

The market has also been influenced by notable technological advances, including automation in production lines, integration of artificial intelligence for quality control, and data-driven approaches to process optimization. These changes have not only reduced manufacturing costs but have also improved the scalability of production, enabling manufacturers to meet surging global demand. Simultaneously, evolving regulatory landscapes have compelled companies to enhance transparency and compliance, directly impacting market operations and long-term strategies.

Simultaneously, industry players are increasingly investing in R&D to explore new applications that extend the traditional boundaries of animal plasma derivatives. There is a clear trend toward interdisciplinary collaborations and partnerships which further accelerate product innovation. With increasing demand in both emerging and established markets, manufacturers are redefining product portfolios to address a broader array of applications ranging from biomedical research to consumer products. These strategic shifts underscore a market in flux, where technological innovation and regulatory evolution are paving the way for sustained industry growth.

Key Segmentation Insights in the Evolving Market

A detailed segmentation analysis provides a clear window into the market dynamics of animal blood plasma products and derivatives. The industry is segmented based on animal type, derivative type, end-user, and application. In terms of animal type, significant emphasis is placed on products derived from avian, bovine, ovine, and porcine sources. Each of these categories brings distinct characteristics that cater to specific product needs in various applications.

Furthermore, the derivative type segmentation encompasses essential products such as fetal bovine serum, fibrinogen, immunoglobulin, serum albumin, and thrombin. These components are fundamental in a wide range of biomedical applications, contributing to both research and therapeutic practices. The end-user segmentation spans food manufacturers, pharmaceutical companies, and veterinary services. This diversity demonstrates the versatility and broad applicability of plasma products in addressing industry-specific challenges.

Application-based segmentation further underscores the market's evolving nature, with products making their mark in areas like animal feed, biomedical research, cell culture media, and food processing. Additional applications include nutrition supplements, pet food industry formulations, pharmaceuticals and cosmetics, as well as tissue engineering. This segmentation insight suggests that the market is highly specialized, with each segment reflecting distinct consumer requirements and technological innovations which drive both product development and strategic market positioning.

Based on Animal Type, market is studied across Avian, Bovine, Ovine, and Porcine.

Based on Derivative Type, market is studied across Fetal Bovine Serum, Fibrinogen, Immunoglobulin, Serum Albumin, and Thrombin.

Based on End-User, market is studied across Food Manufacturers, Pharmaceutical Companies, and Veterinary.

Based on Application, market is studied across Animal Feed, Biomedical Research, Cell Culture Media, Food Processing, Nutrition Supplements, Pet Food Industry, Pharmaceuticals & Cosmetics, and Tissue Engineering.

Essential Regional Insights Shaping Market Trends

The animal blood plasma products and derivatives market exhibits noteworthy regional variations that reflect broader economic, regulatory, and technological influences. In the Americas, robust growth is underpinned by advanced research facilities, a strong biotechnology sector, and an aggressive approach to regulatory compliance. These factors ensure sustained demand among established industry players as well as emerging enterprises. Meanwhile, this region benefits from extensive partnerships that drive innovation and set the pace for quality enhancements in product formulations.

Across the region encompassing Europe, the Middle East, and Africa, the market is evolving at a measured pace. Technological advancements and rigorous quality standards have positioned these areas as key contributors to in-depth scientific research and product development. Companies in this region are strategically investing in state-of-the-art infrastructure and R&D, which has resulted in notable improvements in process efficiency and product consistency. The emphasis on research collaboration and regional regulatory alignment has further facilitated market penetration and international trade.

In the Asia-Pacific region, rapid industrialization coupled with a growing demand for high-quality biologics has established an impressive growth trajectory. Technological integration and increasing investment in biotechnology have catalyzed local market innovation, positioning the region as a critical hub for both production and research. The interplay of these regional insights demonstrates that while each geographic area presents unique challenges, collectively they contribute to a resilient and forward-moving market landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation and Market Growth

The landscape of animal blood plasma products and derivatives is bolstered by the significant contributions of several key market players who not only drive innovation but also contribute to market stability and growth. Leading companies such as ACROBiosystems Inc. and Alfa Laval Corporate AB contribute through cutting-edge research and by setting high production standards in the field. Organizations including ANZCO Foods Limited and Auckland BioSciences Ltd. have expanded the market reach by integrating advanced production facilities with global distribution channels.

Other prominent players, including BioChemed Services, Biowest Company, and Bovogen Biologicals Pty Ltd., further enhance the product quality spectrum by focusing on state-of-the-art derivatization practices. Companies like Canvax Reagents S.L. and Ebrator Biochemicals Inc. emphasize innovation and technological frontiers to ensure that products not only meet but exceed industry standards. Moreover, the contributions of Kraeber & Co. GmbH, Lake Immunogenics, Inc., and LAMPIRE Biological Laboratories, Inc. span global markets by combining research excellence with operational efficiency.

In addition, industry leaders such as Meiji Holdings Co., Ltd., Merck KGaA, and Pel-Freez, LLC have cemented their positions through significant R&D investments that drive competitive advantages. The market also benefits from the strategic insights provided by organizations like Rockland Immunochemicals, Inc., Rocky Mountain Biologicals, Scripps Laboratories, Inc., and Sigma-Aldrich. Collaborations and technological synergies with TCS Biosciences Ltd. and Thermo Fisher Scientific Inc. have led to innovative product lines and enhanced service offerings, thereby reinforcing the market's future prospects.

The report delves into recent significant developments in the Animal Blood Plasma Products & Derivatives Market, highlighting leading vendors and their innovative profiles. These include ACROBiosystems Inc., Alfa Laval Corporate AB, ANZCO Foods Limited, Auckland BioSciences Ltd., BioChemed Services, Biowest Company, Bovogen Biologicals Pty Ltd., Canvax Reagents S.L., Ebrator Biochemicals Inc., Kraeber & Co. GmbH, Lake Immunogenics, Inc., LAMPIRE Biological Laboratories, Inc., Meiji Holdings Co., Ltd., Merck KGaA, Pel-Freez, LLC, Rockland Immunochemicals, Inc., Rocky Mountain Biologicals, Scripps Laboratories, Inc., Sigma-Aldrich, TCS Biosciences Ltd., and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders

Industry decision-makers are positioned to accelerate growth by focusing on advancements in R&D and by streamlining operational efficiencies. Leaders should prioritize investment in next-generation processing technologies that elevate product purity and yield. It is essential to foster strategic partnerships that bridge research institutions with production facilities to harness cutting-edge developments and meet the changing market demands. By actively monitoring regulatory updates and aligning with global standards, companies can mitigate compliance risks while maintaining a competitive edge.

Furthermore, optimizing the supply chain and enhancing quality control measures will support timely market entry and reduce production bottlenecks. Establishing robust data analytics frameworks provides actionable intelligence that informs decision-making processes and tailors product development to the precise needs of diverse market segments. Ultimately, a focused approach that couples technological innovation with operational excellence will enable industry leaders to sustain growth and capitalize on emerging opportunities.

Conclusion and Future Market Prospects

The analysis of animal blood plasma products and derivatives reveals an industry rich in opportunity and resilient against market fluctuations. Driven by technological advancements, insightful segmentation, and an evolving regulatory environment, the market continues to demonstrate robust growth. The integration of innovative production techniques and diversification across various applications has created an ecosystem where research and development lead to tangible, market-ready outcomes.

As the industry moves forward, it is clear that embracing both regional nuances and the strategic insights of key companies will be instrumental in shaping future directions. The balance between quality enhancements and regulatory compliance continues to be a defining factor in enabling market leaders to achieve sustained success. With continued innovation and strategic collaborations, the prospects for the market remain highly promising, offering growth potential that is both extensive and diverse.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for animal meat and protein among human population
      • 5.1.1.2. Rising consumer awareness concerning sustainable and humane animal farming practices globally
      • 5.1.1.3. Expanding utilization of animal blood plasma in veterinary care applications
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations for safety and quality standards for animal blood plasma products
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging use of blood plasma derivatives in cosmetics and skincare for innovative product development
      • 5.1.3.2. Ongoing innovations in biotechnology and processing techniques to improve the quality of animal blood plasma products
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of synthetic alternatives to animal blood plasma products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Animal Type: Rising preference for porcine plasma products owing to high efficiency and amino acid
    • 5.2.2. Application: Increasing significance of animal blood plasma products in pet food industry
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Blood Plasma Products & Derivatives Market, by Animal Type

  • 6.1. Introduction
  • 6.2. Avian
  • 6.3. Bovine
  • 6.4. Ovine
  • 6.5. Porcine

7. Animal Blood Plasma Products & Derivatives Market, by Derivative Type

  • 7.1. Introduction
  • 7.2. Fetal Bovine Serum
  • 7.3. Fibrinogen
  • 7.4. Immunoglobulin
  • 7.5. Serum Albumin
  • 7.6. Thrombin

8. Animal Blood Plasma Products & Derivatives Market, by End-User

  • 8.1. Introduction
  • 8.2. Food Manufacturers
  • 8.3. Pharmaceutical Companies
  • 8.4. Veterinary

9. Animal Blood Plasma Products & Derivatives Market, by Application

  • 9.1. Introduction
  • 9.2. Animal Feed
  • 9.3. Biomedical Research
  • 9.4. Cell Culture Media
  • 9.5. Food Processing
  • 9.6. Nutrition Supplements
  • 9.7. Pet Food Industry
  • 9.8. Pharmaceuticals & Cosmetics
  • 9.9. Tissue Engineering

10. Americas Animal Blood Plasma Products & Derivatives Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Animal Blood Plasma Products & Derivatives Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Animal Blood Plasma Products & Derivatives Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Gemini Bioproducts expands its portfolio by acquiring Bio-Techne's key fetal bovine serum brands
    • 13.3.2. FDA clearance of PrecisePRP Canine transform veterinary care with innovative platelet-rich plasma solution
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ACROBiosystems Inc.
  • 2. Alfa Laval Corporate AB
  • 3. ANZCO Foods Limited
  • 4. Auckland BioSciences Ltd.
  • 5. BioChemed Services
  • 6. Biowest Company
  • 7. Bovogen Biologicals Pty Ltd.
  • 8. Canvax Reagents S.L.
  • 9. Ebrator Biochemicals Inc.
  • 10. Kraeber & Co. GmbH
  • 11. Lake Immunogenics, Inc.
  • 12. LAMPIRE Biological Laboratories, Inc.
  • 13. Meiji Holdings Co., Ltd.
  • 14. Merck KGaA
  • 15. Pel-Freez, LLC
  • 16. Rockland Immunochemicals, Inc.
  • 17. Rocky Mountain Biologicals
  • 18. Scripps Laboratories, Inc.
  • 19. Sigma-Aldrich
  • 20. TCS Biosciences Ltd.
  • 21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET MULTI-CURRENCY
  • FIGURE 2. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET MULTI-LANGUAGE
  • FIGURE 3. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET RESEARCH PROCESS
  • FIGURE 4. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 200. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024